| Literature DB >> 26448834 |
Mahbubeh Moradi1, Mohammad Ali Sahraian2, Aida Aghsaie2, Mohammad Reza Kordi3, Alipasha Meysamie4, Maryam Abolhasani5, Vahid Sobhani6.
Abstract
BACKGROUND: Muscle weakness and fatigue contribute to the reduction of daily activity in multiple sclerosis (MS) patients. Therapeutic strategies to promote improvements in muscle strength and endurance are limited in individuals with MS. Some evidence showed that exercise may improve and affect different aspects of the disease including quality of life, fatigue, motor and cognitive functions.Entities:
Keywords: Motor Activity; Multiple Sclerosis; Muscle Strength; Resistance Training
Year: 2015 PMID: 26448834 PMCID: PMC4592758 DOI: 10.5812/asjsm.6(2)2015.22838
Source DB: PubMed Journal: Asian J Sports Med ISSN: 2008-000X
Resistance Training Program Plan
| Week Variable | 1st Week | 2nd Week | 3rd and 4th Weeks | 5th - 8th Weeks |
|---|---|---|---|---|
|
| 30 minutes | 30 minutes | 30 minutes | 30 minutes |
|
| 50% of 1-RM | 60% of 1-RM | 70% of 1-RM | 80% of 1-RM |
|
| 6-10 | 10-15 | 10-15 | 10-15 |
|
| 1 set | 1 set | 1 set | 1 set |
Baseline Characteristics of Study Patients [a, b]
| Variable | Exercise Group, (n = 8) | Control Group, (n = 10) | P Value |
|---|---|---|---|
|
| 34.38 ± 11.07 | 33.13 ± 7.08 | 0.792 |
|
| 1.75 ± 0.05 | 1.72 ± 0.05 | 0.342 |
|
| 68.06 ± 11.13 | 63.75 ± 9.47 | 0.430 |
|
| 22.15 ± 3.63 | 21.42 ± 3.60 | 0.674 |
|
| 9.38 ± 4.24 (3 - 15) | 9 ± 5.09 (2 - 16) | 0.916 |
|
| 8.12 ± 4.79 (2 - 15) | 6.5 ± 5.78 (1 - 14) | 0.368 |
|
| 3 (1-6) | 3 (1 - 5) | 0.958 |
|
| 6 (75) | 6 (75) | - |
|
| 5/3 | 6/4 | - |
|
| 8.34 ± 4.47 | 7.26 ± 1.55 | 0.52 |
|
| 35.50 ± 20.29 | 23.70 ± 19.80 | 0.28 |
|
| 9.91 ± 2.28 | 10.42 ± 3.31 | 0.705 |
|
| 54.2 ± 11.5 | 38.2 ± 18.5 | 0.052 |
|
| 115.0 ± 12.1 | 95.3 ± 23.5 | 0.254 |
|
| 46.0 ± 8.4 | 26.5 ± 8.9 | 0.001 |
|
| 115.2 ± 26.2 | 99.51 ± 22.5 | 0.262 |
|
| 23.9 ± 26 | 21.4 ± 34.7 | 0.537 |
aAbbreviations: BMI, body mass index; EDSS, Expanded Disability Status Scale; RR, Relapsing Remitting MS; SP, Secondary Progressive MS.
bValues are Mean ± SD, unless otherwise noted.
Primary and Secondary Outcome Measures [a]
| Variables | Exercise Group | Control Group | P Value [ | |||||
|---|---|---|---|---|---|---|---|---|
| Pretest [ | Posttest [ | P Value [ | Pretest [ | Posttest [ | P Value [ | Mean difference (95% CI) | ||
| 10-meter timed walk test | 8.3 ± 4.5 | 6.6 ± 2.0 | 0.118 | 7.3 ± 1.6 | 7.4 ± 1.6 | 0.199 | 1.8 (0.1 - 3.5) | 0.083 |
| Three minutes step test | 35.5 ± 20.3 | 48.8 ± 25.3 | 0.006 | 23.7 ± 19.8 | 19.8 ± 20.7 | 0.248 | 17.2 (7.2 - 27.1) | 0.002 |
| Timed Up and Go test | 9.9 ± 2.3 | 8.1 ± 2.2 | 0.006 | 10.5 ± 3.31 | 10.7 ± 3.27 | 0.444 | 2.2 (1.5 - 2/9) | 0.009 |
|
| ||||||||
| Seated rowing | 115.0 ± 12.1 | 150.3 ± 16.8 | 0.006 | 95.3 ± 23.5 | 91.0 ± 21.1 | 0.040 | 39.7 (29.5 - 48.9) | 0.000 |
| Chest press | 54.2 ± 11.5 | 70.7 ± 11.5 | 0.006 | 38.2 ± 18.5 | 32.7 ± 18.0 | 0.072 | 22.7 (13.1 - 32.3) | 0.000 |
| Leg extension | 46.0 ± 8.4 | 59.9 ± 11.6 | 0.006 | 26.7 ± 8.9 | 22.0 ± 8.9 | 0.021 | 18.50 (12.8 - 24.4) | 0.000 |
| Leg press | 115.2 ± 26.2 | 147.1 ± 23.3 | 0.006 | 99.5 ± 22.5 | 87.8 ± 20.6 | 0.014 | 47.0 (32.4 - 61.6) | 0.000 |
|
| ||||||||
| Flamingo Stand test | 23.9 ± 26.0 | 34.1 ± 36.4 | 0.118 | 21.4 ± 34.7 | 21.6 ± 33.5 | 0.172 | 10.3 (4.6 - 16.5) | 0.407 |
|
| 3.0 ± 1.6 | 1.5 ± 1.4 | 0.037 | 3 ± 1.5 | 3.7 ± 1.5 | 0.033 | 1.8 (0.7 - 3) | |
aAbbreviation: CI, Confidence interval.
dOf change between groups with “group by time interaction” (by Repeated Measure ANOVA).
bPretest and posttest are “mean ± SD” except for EDSS which is “median ± SD”.
cOf change between pretest and posttest (by Wilcoxon Signed Rank Test).